Nathan Bryan, PhD, from Baylor College of Medicine, talks about the importance of nitric oxide in diagnosing and treating pulmonary conditions, including asthma.
He discusses new and emerging agents that may cause drug-induced lung disease, how classic toxicities of medications are presenting differently, and more.
He discusses new and emerging agents that may cause drug-induced lung disease, how classic toxicities of medications are presenting differently, and more.
Dr May, from the University of California, Los Angeles, discusses her research about disparities in colorectal cancer (CRC) screening, how gastroenterologists can help improve CRC screening rates in the...
He discusses his latest research on 2 antifibrotic drugs for the treatment of idiopathic pulmonary fibrosis, which was recently published by the American Thoracic Society.
Laura E. Crotty Alexander, MD, answers our questions about recent documents published by the American Thoracic Society on vaping-associated pulmonary illness and what pulmonologists need to know about this...
Chair of the ATS Tobacco Action Committee, Michelle N. Eakin, PhD, answered our questions about the health effects of vaping, what we know about the long-term effects, and the ongoing studies that will...
